Entera Bio Ltd. (FRA:5DT)
Germany
· Delayed Price · Currency is EUR 1.788
-0.044 (-2.40%)
Last updated: Dec 5, 2025, 10:50 AM CET
Entera Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 0.12 | 0.18 | - | 0.13 | 0.57 | 0.37 | Upgrade
|
| Revenue Growth (YoY) | 25.25% | - | - | -76.53% | 56.44% | 54.66% | Upgrade
|
| Cost of Revenue | 0.12 | 0.17 | - | 0.1 | 0.37 | 0.3 | Upgrade
|
| Gross Profit | - | 0.01 | - | 0.03 | 0.2 | 0.07 | Upgrade
|
| Selling, General & Admin | 5.34 | 5.1 | 4.43 | 7.71 | 5.69 | 4.85 | Upgrade
|
| Research & Development | 5.49 | 4.5 | 4.51 | 5.85 | 6.77 | 6.38 | Upgrade
|
| Other Operating Expenses | - | - | -0.05 | -0.05 | -0.05 | - | Upgrade
|
| Operating Expenses | 10.82 | 9.59 | 8.89 | 13.51 | 12.42 | 11.23 | Upgrade
|
| Operating Income | -10.82 | -9.59 | -8.89 | -13.47 | -12.22 | -11.17 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0.03 | Upgrade
|
| Interest & Investment Income | 0.06 | 0.06 | 0.03 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | -0.03 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0.08 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -10.77 | -9.53 | -8.86 | -13.39 | -12.25 | -11.2 | Upgrade
|
| Other Unusual Items | - | - | - | 0.46 | - | - | Upgrade
|
| Pretax Income | -10.77 | -9.53 | -8.86 | -12.93 | -12.25 | -11.2 | Upgrade
|
| Income Tax Expense | 0.01 | 0.01 | 0.03 | 0.14 | -0.06 | 0.02 | Upgrade
|
| Net Income | -10.78 | -9.54 | -8.89 | -13.07 | -12.19 | -11.22 | Upgrade
|
| Net Income to Common | -10.78 | -9.54 | -8.89 | -13.07 | -12.19 | -11.22 | Upgrade
|
| Shares Outstanding (Basic) | 44 | 38 | 29 | 29 | 26 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 44 | 38 | 29 | 29 | 26 | 18 | Upgrade
|
| Shares Change (YoY) | 25.17% | 29.79% | 0.69% | 10.23% | 41.90% | 51.62% | Upgrade
|
| EPS (Basic) | -0.24 | -0.25 | -0.31 | -0.45 | -0.47 | -0.61 | Upgrade
|
| EPS (Diluted) | -0.24 | -0.25 | -0.31 | -0.45 | -0.47 | -0.61 | Upgrade
|
| Free Cash Flow | -7.09 | -6.82 | -7.33 | -12.55 | -9.08 | -10.61 | Upgrade
|
| Free Cash Flow Per Share | -0.16 | -0.18 | -0.25 | -0.44 | -0.35 | -0.58 | Upgrade
|
| Gross Margin | - | 4.97% | - | 24.63% | 34.68% | 17.81% | Upgrade
|
| Operating Margin | -8729.03% | -5295.58% | - | -10055.22% | -2139.58% | -3059.73% | Upgrade
|
| Profit Margin | -8694.35% | -5271.27% | - | -9754.48% | -2134.33% | -3072.88% | Upgrade
|
| Free Cash Flow Margin | -5715.32% | -3768.51% | - | -9362.69% | -1590.19% | -2906.85% | Upgrade
|
| EBITDA | -10.79 | -9.54 | -8.84 | -13.41 | -12.16 | -11.11 | Upgrade
|
| D&A For EBITDA | 0.03 | 0.05 | 0.06 | 0.06 | 0.05 | 0.06 | Upgrade
|
| EBIT | -10.82 | -9.59 | -8.89 | -13.47 | -12.22 | -11.17 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.